Presentation is loading. Please wait.

Presentation is loading. Please wait.

A randomized controlled study of peanut oral immunotherapy: Clinical desensitization and modulation of the allergic response  Pooja Varshney, MD, Stacie.

Published byМаријан Милинковић Modified over 5 years ago

Similar presentations

Presentation on theme: "A randomized controlled study of peanut oral immunotherapy: Clinical desensitization and modulation of the allergic response  Pooja Varshney, MD, Stacie."— Presentation transcript:

1 A randomized controlled study of peanut oral immunotherapy: Clinical desensitization and modulation of the allergic response  Pooja Varshney, MD, Stacie M. Jones, MD, Amy M. Scurlock, MD, Tamara T. Perry, MD, Alex Kemper, MD, MPH, MS, Pamela Steele, CPNP, Anne Hiegel, RN, Janet Kamilaris, RN, Suzanne Carlisle, RN, Xiaohong Yue, MS, Mike Kulis, PhD, Laurent Pons, PhD, Brian Vickery, MD, A. Wesley Burks, MD  Journal of Allergy and Clinical Immunology  Volume 127, Issue 3, Pages (March 2011) DOI: /j.jaci Copyright © 2011 American Academy of Allergy, Asthma & Immunology Terms and Conditions

2 Fig 1 Cumulative amount of peanut protein ingested at OFC by peanut OIT and placebo subjects (*P < .001) after 12 months of therapy. Individual subjects are shown as diamonds (peanut OIT) or squares (placebo); lines designate median values. Journal of Allergy and Clinical Immunology  , DOI: ( /j.jaci ) Copyright © 2011 American Academy of Allergy, Asthma & Immunology Terms and Conditions

3 Fig 2 Titrated skin prick testing. Change in median wheal size from baseline to time of OFC in peanut OIT and placebo subjects (*P < .001). Boxes represent 25% to 75% quartiles; whiskers represent range. Lines designate median values. Journal of Allergy and Clinical Immunology  , DOI: ( /j.jaci ) Copyright © 2011 American Academy of Allergy, Asthma & Immunology Terms and Conditions

4 Fig 3 Changes in serum immunoglobulin levels during treatment with peanut OIT and placebo. A, Peanut-specific IgE (*P ≤ .01). B, Peanut-specific IgG (*P < .05). C, Peanut-specific IgG4 (*P ≤ .001). Boxes represent 25% to 75% quartiles; whiskers represent range. Lines designate median values. Journal of Allergy and Clinical Immunology  , DOI: ( /j.jaci ) Copyright © 2011 American Academy of Allergy, Asthma & Immunology Terms and Conditions

5 Fig 4 Changes in secreted cytokine responses for subjects receiving peanut OIT and placebo. PBMCs were cultured with peanut protein for 72 hours; cytokines were measured via ELISA. A, IL-5 (*P ≤ .02). B, IL-13 (*P ≤ .03). Journal of Allergy and Clinical Immunology  , DOI: ( /j.jaci ) Copyright © 2011 American Academy of Allergy, Asthma & Immunology Terms and Conditions

6 Fig 5 Change in FoxP3hi: FoxP3intermediate CD4+CD25+ T cells from baseline to time of OFC. PBMCs were stimulated with crude peanut extract and tetanus toxin for 7 days and then stained for Treg markers. Individual subjects are shown for peanut OIT (A) and placebo (B) groups. *P = .04. ns, Not significant. Journal of Allergy and Clinical Immunology  , DOI: ( /j.jaci ) Copyright © 2011 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Download ppt "A randomized controlled study of peanut oral immunotherapy: Clinical desensitization and modulation of the allergic response  Pooja Varshney, MD, Stacie."

Similar presentations

Epigenetic modifications and improved regulatory T-cell function in subjects undergoing dual sublingual immunotherapy  Ravi S. Swamy, MD, Neha Reshamwala,

Epigenetic modifications and improved regulatory T-cell function in subjects undergoing dual sublingual immunotherapy  Ravi S. Swamy, MD, Neha Reshamwala,
Immunologic features of infants with milk or egg allergy enrolled in an observational study (Consortium of Food Allergy Research) of food allergy  Scott.

Immunologic features of infants with milk or egg allergy enrolled in an observational study (Consortium of Food Allergy Research) of food allergy  Scott.
Immunotherapy for Food Allergy: Are We There Yet?

Immunotherapy for Food Allergy: Are We There Yet?
Corinne A. Keet, MD, MS, Pamela A

Corinne A. Keet, MD, MS, Pamela A
A randomized, double-blind, placebo-controlled pilot study of sublingual versus oral immunotherapy for the treatment of peanut allergy  Satya D. Narisety,

A randomized, double-blind, placebo-controlled pilot study of sublingual versus oral immunotherapy for the treatment of peanut allergy  Satya D. Narisety,
Sublingual immunotherapy for peanut allergy: A randomized, double-blind, placebo- controlled multicenter trial  David M. Fleischer, MD, A. Wesley Burks,

Sublingual immunotherapy for peanut allergy: A randomized, double-blind, placebo- controlled multicenter trial  David M. Fleischer, MD, A. Wesley Burks,
Omalizumab facilitates rapid oral desensitization for peanut allergy

Omalizumab facilitates rapid oral desensitization for peanut allergy
Fatty acids, inflammation, and asthma

Fatty acids, inflammation, and asthma
Alison M. Hofmann, MD, Amy M. Scurlock, MD, Stacie M

Alison M. Hofmann, MD, Amy M. Scurlock, MD, Stacie M
Increased peanut-specific IgA levels in saliva correlate with food challenge outcomes after peanut sublingual immunotherapy  Michael Kulis, PhD, Katie.

Increased peanut-specific IgA levels in saliva correlate with food challenge outcomes after peanut sublingual immunotherapy  Michael Kulis, PhD, Katie.
Advances in food allergy in 2015

Advances in food allergy in 2015
Cow's milk epicutaneous immunotherapy in children: A pilot trial of safety, acceptability, and impact on allergic reactivity  Christophe Dupont, MD, PhD,

Cow's milk epicutaneous immunotherapy in children: A pilot trial of safety, acceptability, and impact on allergic reactivity  Christophe Dupont, MD, PhD,
Stacie M. Jones, MD, Scott H. Sicherer, MD, A

Stacie M. Jones, MD, Scott H. Sicherer, MD, A
Santa Jeremy Ono, BA, PhD, Mark B. Abelson, MD 

Santa Jeremy Ono, BA, PhD, Mark B. Abelson, MD 
Ann-Marie M. Schoos, MD, PhD, Jacob D

Ann-Marie M. Schoos, MD, PhD, Jacob D
Evaluation of BCG administration as an adjuvant to specific immunotherapy in asthmatic children with mite allergy  Andrea Cohon, MD, L. Karla Arruda,

Evaluation of BCG administration as an adjuvant to specific immunotherapy in asthmatic children with mite allergy  Andrea Cohon, MD, L. Karla Arruda,
Safety, clinical, and immunologic efficacy of a Chinese herbal medicine (Food Allergy Herbal Formula-2) for food allergy  Julie Wang, MD, Stacie M. Jones,

Safety, clinical, and immunologic efficacy of a Chinese herbal medicine (Food Allergy Herbal Formula-2) for food allergy  Julie Wang, MD, Stacie M. Jones,
Serum vitamin D levels and severe asthma exacerbations in the Childhood Asthma Management Program study  John M. Brehm, MD, MPH, Brooke Schuemann, BS,

Serum vitamin D levels and severe asthma exacerbations in the Childhood Asthma Management Program study  John M. Brehm, MD, MPH, Brooke Schuemann, BS,
Is 9 more than 2 also in allergic airway inflammation?

Is 9 more than 2 also in allergic airway inflammation?
A randomized, double-blind, placebo-controlled study of omalizumab combined with oral immunotherapy for the treatment of cow's milk allergy  Robert A.

A randomized, double-blind, placebo-controlled study of omalizumab combined with oral immunotherapy for the treatment of cow's milk allergy  Robert A.

Similar presentations

Ads by Google